U.S. Healthtech Stock News

If you are trying to figure out whether CRISPR Therapeutics is attractively priced or not, the recent share performance gives you a lot to think about. The stock last closed at US$45.75, with a 1.1% decline over 7 days, a 23.9% decline over 30 days, a 14.9% decline year to date, but a 23.7% gain over 1 year and a 1.1% gain over 3 years compared to a 61.7% decline over 5 years. These shifts in returns have kept CRISPR Therapeutics on many watchlists, as investors weigh shorter term weakness...

In March 2026, global talent solutions and consulting firm Robert Half was named by Fortune as one of America's Most Innovative Companies, highlighting its AI-powered tools and proprietary data-driven capabilities in improving talent matching and client support. This innovation recognition comes as Robert Half continues to contend with declining sales and earnings, underscoring a tension between its technology progress and current business headwinds. Now we will examine how this innovation...

If you are wondering whether Greif is offering fair value at its recent price, this breakdown will help you see how the current share level stacks up against several valuation checks. The stock recently closed at US$66.37, with a 6.0% return over the past 7 days, an 8.7% decline over 30 days, a 3.0% decline year to date, and a 25.2% gain over the past year, which may influence how you think about both upside potential and risk. Those swings sit alongside a longer track record, with returns...

Recent price action and business context Legence (LGN) has drawn fresh attention after a recent share price move, with the stock closing at US$54.75 and showing mixed short term returns over the past week, month and past 3 months. For readers tracking the underlying business, Legence reports US$2.55b in revenue across engineering, installation and maintenance services for mission critical building systems in the United States. These operations are supported by two segments: Engineering &...

Avery Dennison recently issued upbeat guidance ahead of its fiscal Q1 2026 results, with analysts projecting a 5.7% rise in adjusted EPS versus the prior year and highlighting continued strength in high-value areas such as intelligent labels and Vestcom. This focus on higher-margin, technology-driven labeling solutions underscores how Avery Dennison’s growth is increasingly tied to digital identification and data-rich packaging applications. Now we’ll examine how this positive earnings...

If you are wondering whether e.l.f. Beauty at around US$61.05 is a bargain or already pricing in a lot of optimism, this breakdown will help you frame that question clearly. The share price has recently been under pressure, with a 15.8% decline over 7 days, a 33.7% decline over 30 days, and a 21.5% decline year to date, compared with a 5.8% decline over the last year and a 25.9% decline over 3 years. These moves come as investors continue to reassess the broader beauty and personal care...

If you are wondering whether Arista Networks' current share price lines up with its underlying value, you are not alone. This article walks through what the numbers actually say. The stock trades at US$120.77 after a 7 day return of an 8% decline and a 30 day return of a 9.5% decline, set against a 1 year return of 55% and a very large 5 year gain. Recent attention has focused on Arista Networks as investors weigh its role in networking and cloud infrastructure. Headlines frequently link the...

HP (HPQ) just rolled out a wide slate of AI-centric products, including HP IQ software and NearSense connectivity, Z workstations, gaming rigs, and new security tools like TPM Guard and quantum-resistant printers. See our latest analysis for HP. Despite this flurry of AI-focused launches, HP’s recent performance in the market has been mixed, with a 7 day share price return of 6.40% and a 1 year total shareholder return decline of 26.80%. This suggests recent momentum is picking up after a...

Recent performance snapshot Karman Holdings (KRMN) has drawn investor attention after a past year total return of about 140%, alongside a decline of nearly 5% over the past month and a gain of roughly 8% over the past three months. See our latest analysis for Karman Holdings. With the share price at $84.07, Karman Holdings has seen short term pressure, including a 15.4% decline in the 7 day share price return, while its 1 year total shareholder return of about 140% still signals strong longer...

Aerie parent American Eagle Outfitters (AEO) is back in focus after extending its "100% Aerie Real" campaign featuring Pamela Anderson. The move underscores a public stance against AI generated bodies and fully unretouched marketing. See our latest analysis for American Eagle Outfitters. Despite the renewed attention around Aerie’s authenticity push and American Eagle Outfitters’ presence at events like Shoptalk Spring 2026, the share price, now at $16.13, shows a 30 day share price return of...

Investors may be wondering if Signet Jewelers at around US$84 is still offering value, or if the easy money has already been made. The stock has pulled back recently, with a 5.6% decline over the last 7 days and a 12.6% decline over the last 30 days, even though the 1-year return sits at 45.1% and the 5-year return at 55.8%. This recent volatility comes after a period where Signet's share price performance over 3 years and 5 years has been positive overall. This can change how the market...

FedEx (NYSE:FDX) presented the FedEx Global Possibilities Award at Junior Achievement Africa's Company of the Year competition, recognizing a student enterprise focused on reducing vehicle emissions. The company also hosted a career readiness webinar for Marine Corps family scholars, aimed at supporting their transition into the workforce. These initiatives highlight FedEx's recent focus on community impact, sustainability and workforce development alongside its core logistics...

In recent months, KKR has outlined an ambitious growth plan and record US$129.00 billion fundraising, agreed to sell CoolIT Systems to Ecolab for US$4.75 billion, moved to acquire bakery chain Nothing Bundt Cakes for over US$2.00 billion including debt, and backed large-scale data center developments on US Army bases through its CyrusOne stake. Together, these moves highlight how KKR is recycling capital from a very large tech-infrastructure exit into new digital infrastructure and consumer...

Recent performance context Without a specific headline event to point to, ProPetro Holding (PUMP) still stands out for investors watching performance. The stock shows positive returns over the past week, month and past 3 months, alongside double digit annual revenue and net income growth. See our latest analysis for ProPetro Holding. With the share price at US$14.69, ProPetro’s recent trend is firmly upward, with a 30 day share price return of 21.1% and a 90 day share price return of 58.6%,...

Recent Performance Snapshot for Main Street Capital Main Street Capital (MAIN) has drawn attention after a weak stretch, with the share price reflecting a 2.6% decline over the past day and double digit drops over the past month and past 3 months. For investors tracking income focused financials, these returns sit alongside reported annual revenue of US$566.391 million and net income of US$493.398 million, providing a reference point for a closer look at the stock. See our latest analysis for...

Earlier in March 2026, analysts including Wells Fargo and Maxim updated their views on Vertex Pharmaceuticals, highlighting the company’s expanding pipeline in areas such as generalized myasthenia gravis and its efforts to diversify beyond cystic fibrosis. This renewed analyst focus underscores how expectations around Vertex’s next wave of therapies, especially in autoimmune and rare diseases, are increasingly central to the company’s long-term story. We’ll now explore how this heightened...

Nebius Group launched Nebius AI Cloud 3.5, a major platform update introducing advanced serverless features and the latest NVIDIA GPUs. The release is designed to support rapid AI prototyping, industrial automation, and physical AI deployment for developers and enterprises. This product rollout comes as the AI infrastructure market becomes increasingly crowded and competitive. Nebius Group, listed as NasdaqGS:NBIS, is rolling out Nebius AI Cloud 3.5 at a time when its shares trade at...

Why Resideo Technologies is on investors’ radar today Resideo Technologies (REZI) has drawn attention after a recent pullback, with the stock down about 14% over the past month and 7% over the past 3 months, despite a strong 1 year total return near 87%. See our latest analysis for Resideo Technologies. The recent 1 month share price return of about a 14% decline, on top of a 7% decline over 3 months, sits in sharp contrast to the 1 year total shareholder return of roughly 87%. This suggests...

Tidewater (NYSE:TDW) director Darron M. Anderson will step down from the board at the 2026 Annual Meeting. The board will shrink from eight to seven members after Anderson’s planned departure. Anderson is not seeking reelection and is expected to serve out his current term on the Audit and Safety & Sustainability Committees. The company states his decision is not related to any disagreement with management or board policies. Tidewater comes into this board change with its shares at $82.4...

Stoke Therapeutics (STOK) is back in focus after reporting full year 2025 results, with sales of US$184.42 million and a sharply smaller net loss, alongside pipeline progress for STK-002 and zorevunersen. See our latest analysis for Stoke Therapeutics. At a share price of US$32.85, Stoke Therapeutics has given investors a very large 1 year total shareholder return of 355.62%. The 30 day share price return of a 9.78% decline suggests some recent momentum has cooled after a strong run helped by...

Palomar Holdings stock: recent performance snapshot Palomar Holdings (PLMR) has drawn investor attention after a recent pullback, with the share price at $116.83 and negative returns over the past month, past 3 months, year to date, and past year. See our latest analysis for Palomar Holdings. The recent 1 day share price return of a 3.68% decline and 30 day share price return of a 5.56% decline contrast with a 3 year total shareholder return of 111.65%. This suggests that longer term momentum...

The leak of Anthropic's Claude Mythos model has put renewed pressure on application software stocks, and Atlassian (TEAM) was caught in this AI scare trade as investors reassessed sector margins. See our latest analysis for Atlassian. Beyond the latest AI jitters, Atlassian’s 1-day share price return of 4.4% and 7-day return of 11.7% sit within a much steeper 90-day share price decline of 60.3% and a 1-year total shareholder return of 70.1%. This signals pressure that has been building for...

Context for the Recent Move in Amicus Therapeutics (FOLD) Recent trading in Amicus Therapeutics (FOLD) puts the spotlight back on how investors are weighing its rare disease portfolio against current financial metrics, including revenue, profitability, and multi year total returns. See our latest analysis for Amicus Therapeutics. At a share price of US$14.41, recent trading has been fairly muted over days and weeks. However, the 1 year total shareholder return of 70.94% and 5 year total...

Recent share performance and business snapshot With no single event driving headlines, Chubb (CB) has still drawn attention after a recent share pullback. This has invited investors to reassess the insurer’s US$124.2b market value and diversified global operations. See our latest analysis for Chubb. Chubb’s recent 6.4% one month share price pullback contrasts with a 2.9% year to date share price gain and a 9.0% one year total shareholder return. This points to moderating short term momentum...